Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,422 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dose-response relationship of epirubicin in the treatment of postmenopausal patients with metastatic breast cancer: a randomized study of epirubicin at four different dose levels performed by the Danish Breast Cancer Cooperative Group.
Bastholt L, Dalmark M, Gjedde SB, Pfeiffer P, Pedersen D, Sandberg E, Kjaer M, Mouridsen HT, Rose C, Nielsen OS, Jakobsen P, Bentzen SM. Bastholt L, et al. Among authors: rose c. J Clin Oncol. 1996 Apr;14(4):1146-55. doi: 10.1200/JCO.1996.14.4.1146. J Clin Oncol. 1996. PMID: 8648369 Clinical Trial.
A randomized study of epirubicin at four different dose levels in advanced breast cancer. Feasibility of myelotoxicity prediction through single blood-sample measurement.
Jakobsen P, Bastholt L, Dalmark M, Pfeiffer P, Petersen D, Gjedde SB, Sandberg E, Rose C, Nielsen OS, Mouridsen HT. Jakobsen P, et al. Among authors: rose c. Cancer Chemother Pharmacol. 1991;28(6):465-9. doi: 10.1007/BF00685824. Cancer Chemother Pharmacol. 1991. PMID: 1934250 Clinical Trial.
Endocrine therapy of advanced breast cancer.
Rose C, Mouridsen HT. Rose C, et al. Acta Oncol. 1988;27(6A):721-8. doi: 10.3109/02841868809091775. Acta Oncol. 1988. PMID: 3064777 Clinical Trial.
Concurrent tamoxifen (TAM) + cyclophosphamide, epirubicin, and fluorouracil (CEF) versus TAM + delayed CEF after six months of endocrine therapy in metastatic breast cancer--a randomized trial from the Danish Breast Cancer Cooperative Group (DBCG).
Pfeiffer P, Rose C, Ejlertsen B, Andersson M, Pedersen D, Mouridsen HT. Pfeiffer P, et al. Among authors: rose c. Acta Oncol. 1996;35 Suppl 5:57. doi: 10.3109/02841869609083970. Acta Oncol. 1996. PMID: 9142967 Clinical Trial. No abstract available.
Doxorubicin versus methotrexate both combined with cyclophosphamide, 5-fluorouracil and tamoxifen in postmenopausal patients with advanced breast cancer--a randomised study with more than 10 years follow-up from the Danish Breast Cancer Cooperative Group. Danish Breast Cancer Cooperative Group (DBCG).
Andersson M, Madsen EL, Overgaard M, Rose C, Dombernowsky P, Mouridsen HT. Andersson M, et al. Among authors: rose c. Eur J Cancer. 1999 Jan;35(1):39-46. doi: 10.1016/s0959-8049(98)00354-2. Eur J Cancer. 1999. PMID: 10211086 Clinical Trial.
2,422 results